GE Healthcare to Distribute Osprey Medical’s Technology to Address Angiography Based Acute Kidney Injury
Under the four-year agreement, GE Healthcare will commercialize Osprey’s DyeVert portfolio which reduces the amount of contrast that reaches the kidney (40% average reduction) with no compromise in image quality.
Lantheus and GE Healthcare Announce the Signing of a Definitive License Agreement for Worldwide Development and Commercialization of Flurpiridaz F 18
Companies also announce the extension and expansion of their existing commercial supply agreement for nuclear products through...
Innovative seven-year collaboration is first of its kind in New England Powered by advanced analytics and...